UNSPSC 51391611: Aminophylline hydrate

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula 2C7H8N4O2.C2H8N2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7E0LU9ZMS. European Medicines Agency schedules aminophylline hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00461MIG. Most nations, for tariff and trade purposes, schedule aminophylline hydrate under HS 29395900. SMILES: CN1C2C(C(=O)N(C1=O)C)[NH]CN2.CN1C2C(C(=O)N(C1=O)C)[NH]CN2.C(CN)N.O.

UNSPSC 51391611 Aminophylline hydrate is a Commodity code that shows minimal alignment with recent state and local solicitation activity. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — sought procurement of Naloxone and Safe Drug Deactivation Systems, pharmaceutical products unrelated to aminophylline hydrate, a theophylline-based respiratory medication. The mismatch suggests either a tagging error or that this code does not reflect the actual pharmaceutical and medical-supply procurement occurring in state and local contracting today.

Seminole County, Florida issued the sole recent solicitation identified under this code, requesting 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The IFB required electronic bid submission through the county's e-Procurement Portal, included two-year initial contract terms with optional one-year renewal, and mandated E-Verify compliance, drug-free workplace certification, and specified insurance coverage. No geographic spread across multiple states or issuing-body types is evident from available recent activity; the code shows insufficient current market activity to characterize demand patterns or procurement trends among state and local buyers.